Biologics Safety Testing Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2016 and Forecast 2017 to 2024

Market Outline: Global Biologics Safety Testing Market
Biologics are the large and complex molecules derived from the genes of living organisms by advanced DNA technologies. Biologics are commonly used in the treatment of chronic diseases such as rheumatoid arthritis, cancer, and other chronic diseases. These biologics are complex molecules such as recombinant proteins and monoclonal antibodies among others. Biologics safety testing is carried to ensure the patient safety. Biological safety testing is carried by using various tests such as sterility tests, endotoxins test, residual host contamination detection tests, and bioburden tests among others.

Market Dynamics: Biologics Safety Testing Market
Growing biologic products launches, rise R&D activities by pharmaceutical and biotechnology companies, technological advancements of biologics safety testing methods, stringent regulatory guidelines for product approval, and rise in funding from public and private sectors for the development of newer biologics are exepcted to boost the biologics safety testing market over the forecast period. However, high cost of biologics safety testing, and lack of well-developed healthcare in underdeveloped countries are hamper the growth of biologics safety testing market.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/biologics-safety-testing-market/#ulp-4H8Z4LpNMLEuOnnx


Market Scope: Biologics Safety Testing Market
Biologics safety testing market is segmented on the basis of product type, test type, application, and end user
Based on the product type, biologics safety testing market segmented into the following:
• Reagents and Kits
• Instruments
• Services
Based on the test type, biologics safety testing market segmented into the following:
• Sterility Tests
• Bioburden Tests
• Endotoxin Tests
• Residual Host Contamination detection Tests
• Cell Line Authentication and Characterization Tests
• Others
Based on the application, biologics safety testing market segmented into the following:
• Cellular and Gene Therapy
• Vaccine and Therapeutics Development
• Tissue and Tissue-related Products Testing
• Blood and Blood-related Products Testing
• Stem Cell Research
Based on end-user, biologics safety testing market segmented into the following:
• Pharmaceutical Companies
• Biotechnology Companies


To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/biologics-safety-testing-market/#ulp-c654SbFYO64MsOhu

Market Summary: Biologics Safety Testing Market
Biologics safety testing market exhibiting lucrative growth, which is attributed to increase in the R&D for the development of newer biologics by pharmaceutical and biopharmaceutical companies for the treatment of chronic diseases such as diabetes, cancer and innovation of newer biologics safety tests. Moreover, rise in funding from the government, and increase in the prevalence of chronic diseases are anticipated to fuel the biologics safety testing market over the forecast period. Furthermore, acquisitions and mergers, collaborations, and launching of newer tests by market players also immensely boost to the biologics safety testing market. For instance, in June 2016, Charles River Laboratories acquired Blue Stream laboratories to strengthen its capabilities in biologics development and safety assessments. In addition in March 2016, Abreos Biosciences collaborated with True Diagnostics to develop the point-of-care tests for biologics.

Regional Analysis: Biologics Safety Testing Market
Geographically, global biologics safety testing market segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America biologics safety testing market expected to hold dominant share owing to increase in R&D activities by the market players, presence of huge number of market players, and well-developed healthcare infrastructure. Europe biologics safety testing market has a significant share owing to adoption of newer technologies, expansion of business by market players in Germany and UK, and increase in funding for R&D activities for the development of newer biologics. For instance, in 2013, European Research Council awarded $830 Mn for life sciences research in Europe. Asia Pacific biologics safety testing market is projected to grow due to rise in awareness about biologics safety testing, favorable regulatory policies, and increase in healthcare expenditure.


Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/biologics-safety-testing-market/#ulp-14mlyhjMGhVjZqa3

Competition Assessment: Biologics Safety Testing Market
Some of the players in the global biologics safety testing market include:
• Charles River Laboratories (U.S.),
• Pace Analytical Services Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• WuXi Apptec (China)
• Sartorius AG (Germany)
• Toxikon Corporation (U.S.)
• Cytovance Biologics, Inc. (U.S.)
• SGS SA (Switzerland)
• Merck KGaA (Germany)
• Sterigenics International, LLC (U.S.)
• Abreos Biosciences (U.S.)
• True Diagnostics, Inc. (U.S.)

Notable Market Developments: Biologics Safety Testing Market
• In October 2017, Sterigenics International LLC acquired Toxikon’s European laboratory business including biologics testing business

Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2013 to 2016) and forecast (2017 to 2024)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/biologics-safety-testing-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.